论文部分内容阅读
作者对27例确诊的多发性硬化(MS)患者测定血红蛋白(Hb)和平均红细胞体积(MCV)等,以研究MS与巨红细胞增多症的关系,其中男11,女16,年龄17～64岁(平均40.6岁)。并取年龄、性别相匹配的26例其它神经科患者作对照。结果如下:1.MS组与对照组的Hb无差异,各为11.6～16.4克%(平均14.0)和12.2～16.2克%(平均14.03)。2.两组MCV各为91.9±4.8fl和88.65±4.13fl。MS组虽属轻度升高,但有非常显著的差异(P=0.011)。与实验室正常值(87.0±5.5)相比亦有非常显著差异(P<0.001)。而对照组与正常值无差异。3.个别MS患者和与其相匹配的对照患者的MCV比较,前者明显升高(平均差异3.35fl,P值=0.015)。MS组之
The authors studied the relationship between MS and mastocytosis in 27 patients with multiple sclerosis (MS) who were diagnosed with hemoglobin (Hb) and mean corpuscular volume (MCV), among whom 11 were men and 16 were women aged 17-64 years (Average 40.6 years old). Twenty-six patients with other neurological age-matched and gender-matched controls were used as controls. The results are as follows: 1. There was no difference in the Hb between the MS group and the control group (11.6-16.4 g% (average 14.0) and 12.2-16.2 g% (average 14.03), respectively). 2. The two groups of MCV each 91.9 ± 4.8fl and 88.65 ± 4.13fl. Although MS group was slightly elevated, there was a significant difference (P = 0.011). There was also a significant difference (P <0.001) from the normal value of the laboratory (87.0 ± 5.5). The control group and normal no difference. 3. The MCVs in the individual MS patients and their matched control patients were significantly higher (mean difference 3.35fl, P = 0.015). MS group